Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist’s, Clinician’s, and Patient’s Perspective

Marta Cossu, Lorenzo Beretta, Petra Mosterman, Maria J.H. de Hair, Timothy R.D.J. Radstake

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Systemic sclerosis (SSc) is a highly heterogeneous disease caused by a complex molecular circuitry. For decades, clinical and molecular research focused on understanding the primary process of fibrosis. More recently, the inflammatory, immunological and vascular components that precede the actual onset of fibrosis, have become a matter of increasing scientific scrutiny. As a consequence, the field has started to realize that the early identification of this syndrome is crucial for optimal clinical care as well as for understanding its pathology. The cause of SSc cannot be appointed to a single molecular pathway but to a multitude of molecular aberrances in a spatial and temporal matter and on the backbone of the patient’s genetic predisposition. These alterations underlie the plethora of signs and symptoms which patients experience and clinicians look for, ultimately culminating in fibrotic features. To solve this complexity, a close interaction among the patient throughout its “journey,” the clinician through its clinical assessments and the researcher with its experimental design, seems to be required. In this review, we aimed to highlight the features of SSc through the eyes of these three professionals, all with their own expertise and opinions. With this unique setup, we underscore the importance of investigating the role of environmental factors in the onset and perpetuation of SSc, of focusing on the earliest signs and symptoms preceding fibrosis and on the application of holistic research approaches that include a multitude of potential molecular alterations in time in an unbiased fashion, in the search for a patient-tailored cure.

Original languageEnglish
Pages (from-to)312-331
Number of pages20
JournalClinical Reviews in Allergy and Immunology
Volume55
Issue number3
DOIs
Publication statusPublished - 2018

Fingerprint

Systemic Scleroderma
Fibrosis
Signs and Symptoms
Therapeutics
Genetic Predisposition to Disease
Research
Blood Vessels
Research Design
Research Personnel
Pathology

Keywords

  • Clinical unmet needs
  • Patient-reported outcomes (PROs)
  • Personalized medicine
  • Systemic sclerosis

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Unmet Needs in Systemic Sclerosis Understanding and Treatment : the Knowledge Gaps from a Scientist’s, Clinician’s, and Patient’s Perspective. / Cossu, Marta; Beretta, Lorenzo; Mosterman, Petra; de Hair, Maria J.H.; Radstake, Timothy R.D.J.

In: Clinical Reviews in Allergy and Immunology, Vol. 55, No. 3, 2018, p. 312-331.

Research output: Contribution to journalArticle

@article{14040537d1e249be9d9e4cfc996365df,
title = "Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist’s, Clinician’s, and Patient’s Perspective",
abstract = "Systemic sclerosis (SSc) is a highly heterogeneous disease caused by a complex molecular circuitry. For decades, clinical and molecular research focused on understanding the primary process of fibrosis. More recently, the inflammatory, immunological and vascular components that precede the actual onset of fibrosis, have become a matter of increasing scientific scrutiny. As a consequence, the field has started to realize that the early identification of this syndrome is crucial for optimal clinical care as well as for understanding its pathology. The cause of SSc cannot be appointed to a single molecular pathway but to a multitude of molecular aberrances in a spatial and temporal matter and on the backbone of the patient’s genetic predisposition. These alterations underlie the plethora of signs and symptoms which patients experience and clinicians look for, ultimately culminating in fibrotic features. To solve this complexity, a close interaction among the patient throughout its “journey,” the clinician through its clinical assessments and the researcher with its experimental design, seems to be required. In this review, we aimed to highlight the features of SSc through the eyes of these three professionals, all with their own expertise and opinions. With this unique setup, we underscore the importance of investigating the role of environmental factors in the onset and perpetuation of SSc, of focusing on the earliest signs and symptoms preceding fibrosis and on the application of holistic research approaches that include a multitude of potential molecular alterations in time in an unbiased fashion, in the search for a patient-tailored cure.",
keywords = "Clinical unmet needs, Patient-reported outcomes (PROs), Personalized medicine, Systemic sclerosis",
author = "Marta Cossu and Lorenzo Beretta and Petra Mosterman and {de Hair}, {Maria J.H.} and Radstake, {Timothy R.D.J.}",
year = "2018",
doi = "10.1007/s12016-017-8636-1",
language = "English",
volume = "55",
pages = "312--331",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Unmet Needs in Systemic Sclerosis Understanding and Treatment

T2 - the Knowledge Gaps from a Scientist’s, Clinician’s, and Patient’s Perspective

AU - Cossu, Marta

AU - Beretta, Lorenzo

AU - Mosterman, Petra

AU - de Hair, Maria J.H.

AU - Radstake, Timothy R.D.J.

PY - 2018

Y1 - 2018

N2 - Systemic sclerosis (SSc) is a highly heterogeneous disease caused by a complex molecular circuitry. For decades, clinical and molecular research focused on understanding the primary process of fibrosis. More recently, the inflammatory, immunological and vascular components that precede the actual onset of fibrosis, have become a matter of increasing scientific scrutiny. As a consequence, the field has started to realize that the early identification of this syndrome is crucial for optimal clinical care as well as for understanding its pathology. The cause of SSc cannot be appointed to a single molecular pathway but to a multitude of molecular aberrances in a spatial and temporal matter and on the backbone of the patient’s genetic predisposition. These alterations underlie the plethora of signs and symptoms which patients experience and clinicians look for, ultimately culminating in fibrotic features. To solve this complexity, a close interaction among the patient throughout its “journey,” the clinician through its clinical assessments and the researcher with its experimental design, seems to be required. In this review, we aimed to highlight the features of SSc through the eyes of these three professionals, all with their own expertise and opinions. With this unique setup, we underscore the importance of investigating the role of environmental factors in the onset and perpetuation of SSc, of focusing on the earliest signs and symptoms preceding fibrosis and on the application of holistic research approaches that include a multitude of potential molecular alterations in time in an unbiased fashion, in the search for a patient-tailored cure.

AB - Systemic sclerosis (SSc) is a highly heterogeneous disease caused by a complex molecular circuitry. For decades, clinical and molecular research focused on understanding the primary process of fibrosis. More recently, the inflammatory, immunological and vascular components that precede the actual onset of fibrosis, have become a matter of increasing scientific scrutiny. As a consequence, the field has started to realize that the early identification of this syndrome is crucial for optimal clinical care as well as for understanding its pathology. The cause of SSc cannot be appointed to a single molecular pathway but to a multitude of molecular aberrances in a spatial and temporal matter and on the backbone of the patient’s genetic predisposition. These alterations underlie the plethora of signs and symptoms which patients experience and clinicians look for, ultimately culminating in fibrotic features. To solve this complexity, a close interaction among the patient throughout its “journey,” the clinician through its clinical assessments and the researcher with its experimental design, seems to be required. In this review, we aimed to highlight the features of SSc through the eyes of these three professionals, all with their own expertise and opinions. With this unique setup, we underscore the importance of investigating the role of environmental factors in the onset and perpetuation of SSc, of focusing on the earliest signs and symptoms preceding fibrosis and on the application of holistic research approaches that include a multitude of potential molecular alterations in time in an unbiased fashion, in the search for a patient-tailored cure.

KW - Clinical unmet needs

KW - Patient-reported outcomes (PROs)

KW - Personalized medicine

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=85028741634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028741634&partnerID=8YFLogxK

U2 - 10.1007/s12016-017-8636-1

DO - 10.1007/s12016-017-8636-1

M3 - Article

AN - SCOPUS:85028741634

VL - 55

SP - 312

EP - 331

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 3

ER -